APA (7th ed.) Citation

Ludolph, A. C., Schuster, J., Dorst, J., Dupuis, L., Dreyhaupt, J., Weishaupt, J. H., . . . Göricke, B. (2018). Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: A randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial. The lancet, 17(8), . https://doi.org/10.1016/S1474-4422(18)30176-5

Chicago Style (17th ed.) Citation

Ludolph, Albert C., et al. "Safety and Efficacy of Rasagiline as an Add-on Therapy to Riluzole in Patients with Amyotrophic Lateral Sclerosis: A Randomised, Double-blind, Parallel-group, Placebo-controlled, Phase 2 Trial." The Lancet 17, no. 8 (2018). https://doi.org/10.1016/S1474-4422(18)30176-5.

MLA (9th ed.) Citation

Ludolph, Albert C., et al. "Safety and Efficacy of Rasagiline as an Add-on Therapy to Riluzole in Patients with Amyotrophic Lateral Sclerosis: A Randomised, Double-blind, Parallel-group, Placebo-controlled, Phase 2 Trial." The Lancet, vol. 17, no. 8, 2018, https://doi.org/10.1016/S1474-4422(18)30176-5.